Pharmacogenetic testing shows promise improving symptoms in patients with treatment-resistant depression
Americans ease up on masks, virus safeguards: AP-NORC poll
29 March 2022Immune cells produce chemical messenger that prevents heart disease–related inflammation
29 March 2022Pharmacogenetic testing shows promise improving symptoms in patients with treatment-resistant depression
Pharmacogenetic testing was associated with nearly a two-fold (89%) increase in remission rates compared to treatment as usual in a Centre for Addiction and Mental Health- (CAMH-)led clinical study just published in the journal Translational Psychiatry.
